Apimeds Pharmaceuticals (APUS) Stock Price, Quote, News & History

Apimeds Pharmaceuticals Us Inc (APUS) Stock Price, Quote, News & History

APUSAMEX

Trade with Public

$1.88

0.137.43%

At close: Apr 1, 5:00 PM EST

Key Statistics

Open

$1.88

Volume / Avg.

0 / 23.67K

Day Range

- - -

52 Wk Range

1.61 - 40.31

Market Cap

$2.36M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

Days to Cover

Recent Apimeds Pharmaceuticals US Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.21M

Investing Cash Flow (TTM)

-35.91K

Financing Cash Flow (TTM)

12.20M

Free Cash Flow (TTM)

-5.24M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

6.96M

Valuation Metrics

Enterprise Value

$17.16M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.90

Earnings Yield % (TTM)

-21.81%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.65

Company Debt

Total Debt

$500.00K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$6.99M

Debt to Equity

0.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.88

Volume / Avg.

0 / 23.67K

Day Range

- - -

52 Wk Range

1.61 - 40.31

Market Cap

$2.36M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Apimeds Pharmaceuticals Us Inc is a clinical-stage company. It is engaged in a pharmaceutical business that provides the biological drug Apitox to clients in the biological drug commercial transaction area. It are a clinical stage biopharmaceutical c...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Apimeds Pharmaceuticals (APUS) stock?

You can purchase shares of Apimeds Pharmaceuticals (AMEX:APUS) through any online brokerage.

View our list of the best stock brokerages

Who are Apimeds Pharmaceuticals (APUS) competitors?

Other companies in Apimeds Pharmaceuticals’s space includes: BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).

What is the forecast, or price target, for Apimeds Pharmaceuticals (APUS) stock?

There is no analysis for Apimeds Pharmaceuticals to provide a consensus price target.

What is the current price for Apimeds Pharmaceuticals (APUS)?

The stock price for Apimeds Pharmaceuticals (AMEX: APUS) is $1.88 last updated April 2, 2026 at 8:00 PM EDT.

Does Apimeds Pharmaceuticals (APUS) pay a dividend?

There are no upcoming dividends for Apimeds Pharmaceuticals.

When is Apimeds Pharmaceuticals (AMEX:APUS) reporting earnings?

Apimeds Pharmaceuticals does not have any upcoming earnings scheduled.

Is Apimeds Pharmaceuticals (APUS) going to split?

There is no upcoming split for Apimeds Pharmaceuticals.

What sector and industry does Apimeds Pharmaceuticals (APUS) operate in?

Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Neurocrine Biosciences Inc

NASDAQ:NBIX

$126.32

Ionis Pharmaceuticals Inc

United Therapeutics Corp

Key Statistics

Open

$1.88

Volume / Avg.

0 / 23.67K

Day Range

- - -

52 Wk Range

1.61 - 40.31

Market Cap

$2.36M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

Days to Cover

Recent Apimeds Pharmaceuticals US Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.21M

Investing Cash Flow (TTM)

-35.91K

Financing Cash Flow (TTM)

12.20M

Free Cash Flow (TTM)

-5.24M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

6.96M

Valuation Metrics

Enterprise Value

$17.16M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.90

Earnings Yield % (TTM)

-21.81%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.65

Company Debt

Total Debt

$500.00K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$6.99M

Debt to Equity

0.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.88

Volume / Avg.

0 / 23.67K

Day Range

- - -

52 Wk Range

1.61 - 40.31

Market Cap

$2.36M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry